학술논문
822P Phase II clinical trial: Safety and efficacy study of tocilizumab (Toci) in combination with ipilimumab (Ipi) 3mg/kg plus nivolumab (Nivo) 1mg/kg in patients (pts) with metastatic melanoma (MM)
Document Type
Abstract
Author
Source
In Annals of Oncology September 2022 33 Supplement 7:S923-S923
Subject
Language
ISSN
0923-7534